As we approach the end of 2024, Leaderboard Branding proudly stands at the forefront of pharmaceutical branding, showcasing our unparalleled expertise across a diverse range of therapeutic areas. From neurology to oncology, dermatology to endocrinology, we have consistently delivered and supported innovative brands, solidifying our position as industry leaders.

At Leaderboard, our experts are global! Meet Dan Hunt, Managing Director, Europe from Basel, Switzerland. Dan brings decades of branding experience, reinforcing Leaderboard Brandings' commitment to providing best-in-class, global, naming and branding services. 

The first letter of a drug's name can offer intriguing insights into patterns of pharmaceutical nomenclature. While no strict rules guide the naming conventions, trends show that certain letters of the alphabet are more commonly used than others. Various factors including linguistics, phonetics, and marketing strategies influence these trends.

When it comes to trademarks, not all brand names are created equal and the ability of a name to be protected through trademark law often depends on where it falls within the spectrum of distinctiveness. Ranging from very distinctive to not at all, let’s take a deeper look into the five labels on the distinctiveness spectrum.

Some brand refreshes can be impactful without making grand alterations. Think about optimizing a brand tone of voice, key messages, or reasons to believe. These strategies may not alert the presses, but these small optimizations could enable conversion for potential customers in the least. 

You may have heard of biologics and biosimilars but may be wondering about their similarities, and differences, and what they mean for treatments. While they each provide treatment options for conditions like arthritis and cancer, these products aren’t carbon copies of each other in every sense. Biologics revolutionized the industry, but biosimilars are assisting in advancing these therapies to improve accessibility to lifesaving treatments.